URGING THE GOVERNOR, DEPARTMENT OF HUMAN SERVICES, AND DEPARTMENT OF HEALTH TO EXPLORE AVENUES TO ENSURE CONTINUED ACCESS TO AFFORDABLE MEDICATIONS FOR THE STATE'S UNDERSERVED POPULATIONS UNDER THE 340B DRUG PRICING PROGRAM AND URGING HAWAII'S CONGRESSIONAL DELEGATION AND RELEVANT FEDERAL AGENCIES TO MONITOR PHARMACEUTICAL COMPANIES AND TAKE APPROPRIATE ACTIONS TO PROTECT THE INTEGRITY OF THE 340B DRUG PRICING PROGRAM.

Latest action: The committee(s) on HHS deleted the measure from the public hearing scheduled on 04-17-24 8:45AM; CR 225 & Videoconference.

Voted 4/12/2024

Roll-call record

How representatives voted

17 yea·0 nay·4 other

Docket history

4/12/2024The committee(s) on HHS deleted the measure from the public hearing scheduled on 04-17-24 8:45AM; CR 225 & Videoconference.
4/11/2024The committee(s) on HHS has scheduled a public hearing on 04-17-24 8:45AM; Conference Room 225 & Videoconference.
4/5/2024Referred to HHS.
4/5/2024Received from House (Hse. Com. No. 637).
4/4/2024Transmitted to Senate.
4/4/2024Adopted with none voting aye with reservations; none voting no (0) and Representative(s) Kitagawa, Quinlan, Souza excused (3).
4/4/2024Reported from FIN (Stand. Com. Rep. No. 1642-24), recommending adoption.
4/2/2024The committee on FIN recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 13 Ayes: Representative(s) Yamashita, Kitagawa, Aiu, Chun, Cochran, Garrett, Kahaloa, Kila, Kobayashi, Lamosao, Poepoe, Takenouchi, Alcos; Ayes with reservations: none; 0 Noes: none; and 3 Excused: Representative(s) Morikawa, Nishimoto, Ward.
3/28/2024Scheduled for decision making on Tuesday, 04-02-24 2:15PM in conference room 308 VIA VIDEOCONFERENCE.
3/28/2024Report adopted. referred to the committee(s) on FIN as amended in HD 1 with none voting aye with reservations; none voting no (0) and Representative(s) Gates, Ichiyama, Kila, Lowen, Tam excused (5).